Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LNG-IUD plus metformin versus megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma
ChiCTR2200055624Phase 2Recruiting
- Sponsor
- Shenyang Women’s and Children’s Hospital
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of avatrombopag, megestrol and metformin in Endometrial intraepithelial neoplasia (EIN) and endometrial cancer (EC) (2 arms), sponsored by Shenyang Women’s and Children’s Hospital. Primary endpoints: Complete response rate, Pregnancy outcome and 1 more. Started Aug 2021; status: recruiting.
02
Drugs
avatrombopagmegestrolmetformin
03
Conditions
Endometrial intraepithelial neoplasia (EIN)endometrial cancer (EC)
Beyond the preview
Go deeper on ChiCTR2200055624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055624.